Navigation Links
Circassia Initiates Phase II Trials of Novel Grass and Ragweed Allergy Therapies and Advances Phase III Plans for cat Allergy T-Cell Vaccine
Date:9/30/2010

s">Products & Services
  • Knowledge Center
  • Browse News Releases
  • Contact PR Newswire
  • Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Clinical Trials & Medical Discoveries Click to view news release full screen  

    Circassia Initiates Phase II Trials of Novel Grass and Ragweed Allergy Therapies and Advances Phase III Plans for cat Allergy T-Cell Vaccine

       

    Extended Clinical Portfolio Now Includes Four Mid-Stage Development Programmes

    OXFORD, England, September 30, 2010 /PRNewswire/ -- Circassia Ltd, a specialty
    '/>"/>

    SOURCE Circassia Ltd
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine
    2. Circassia Acquires North American and Japanese Rights to Dopexamine
    3. Cylene Initiates Phase I Trial in Multiple Myeloma With CX-4945 Inhibitor of CK2 and Closes Accompanying Financing
    4. Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402.
    5. Pieris Initiates Phase I Clinical Trial for Lead Anticalin Compound
    6. Onyx Pharmaceuticals Initiates Phase 1 Study of Oral Proteasome Inhibitor in Advanced Solid Tumors
    7. NewLink Initiates Pivotal Phase 3 Clinical Trial of HyperAcute(R)-Pancreas Immunotherapy for Resected Pancreatic Cancer
    8. Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-111 and Herceptin in Patients with Advanced Her2 Positive Breast Cancer
    9. Fibrocell Science, Inc. Initiates Histology Study of azficel-T
    10. Chimerix Initiates Phase 1 Study of CMX157
    11. Sanofi-aventis Initiates 10,000 Patient Study With Multaq(R) in Permanent AF
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... , Aug. 21, 2014  Decision Resources ... Brazil and Mexico ... uptake of several newly approved agents, the anticipated ... indication and the launch of emerging biologics will ... In particular, the emerging IL-5 inhibitors will introduce ...
    (Date:8/21/2014)... Cord Blood Corporation (NYSE: CO ) (the ... for the first quarter of fiscal year 2015 on ... US.  The Company will host a ... 29, 2014 to discuss its financial performance and give ... by a question and answer session.  Interested parties may ...
    (Date:8/21/2014)... 21, 2014 Ontotext S4 , ... Ontotext . Now the same enterprise hardened ... structured and unstructured data is available to start-ups and ... enterprise technology. Organizations that do not have resources to ... can use S4 since there is no need for ...
    (Date:8/21/2014)... August 21, 2014 On Wednesday of last ... to use Redox Signaling molecules, became available for purchase in ... , "The way that RENU 28 works is, if you ... down of the rate of cellular renewal within your body. ... increasing of that rate of cellular renewal. What RENU 28 ...
    Breaking Biology Technology:Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4RENU 28 Skin Care Now Available in Australia and New Zealand 2
    ... 16, 2011 Genesis Biopharma, Inc. (OTC ... developing targeted cancer therapies, today announced it is expanding ... various cancers.  The Company will focus on establishing a ... new strategy will be discussed during a presentation today ...
    ... SAN DIEGO, March 15, 2011 PR Newswire, ... solutions, today announced the extension of their exclusive ... be the preferred provider of content distribution services ... science association. (Logo: http://photos.prnewswire.com/prnh/20000306/PRNLOGO) ...
    ... Biotechnology company ImmusanT, Inc. today announced it ... is advancing its strategy to develop an immunotherapeutic ... disease. The company completed the acquisition of a ... Ltd., based in Melbourne, Australia, and secured seed ...
    Cached Biology Technology:Genesis Biopharma Announces Plans to Develop Active Immunotherapy Platform 2PR Newswire and BIOCOM Purchasing Group Announce Renewal of Exclusive Partnership 2PR Newswire and BIOCOM Purchasing Group Announce Renewal of Exclusive Partnership 3Start-Up ImmusanT Seeks to Restore Tolerance to Gluten in Celiac Disease with Immunotherapy 2Start-Up ImmusanT Seeks to Restore Tolerance to Gluten in Celiac Disease with Immunotherapy 3Start-Up ImmusanT Seeks to Restore Tolerance to Gluten in Celiac Disease with Immunotherapy 4
    (Date:8/22/2014)... the 29th Annual International Papillomavirus Conference shows that ... combats three types of human papillomavirus, including the ... cancer. , When tested in several cultured human ... HPV-18 and HPV-11 cells, according to Louise T. ... the findings at the Seattle conference. The National ...
    (Date:8/22/2014)... can probably remember the after-effects, including pain, swelling or ... back against the injury. When tissue in the body ... tissue regeneration. An inflammatory response acts as a protective ... to heal after injuries such as wounds and burns. ... situations in which foreign material is introduced, for example ...
    (Date:8/22/2014)... tea polyphenols are strong antioxidants and can ... spinal cord neurons against oxidative stress? Jianbo ... Hospital of Liaoning Medical University, China discovered ... stress and inhibit neuronal apoptosis, indicating green ... spinal cord neurons under oxidative stress. The ...
    Breaking Biology News(10 mins):Tissue regeneration using anti-inflammatory nanomolecules 2
    ... have won national awards for their research on the ... northern spotted owl. Martin Raphael and Eric Forsman, research ... Station, were named recipients of the Wings Across the ... the station,s Olympia, Wash., lab and Forsman at the ...
    ... barrier (BBB) remains a major obstacle to the successful ... disorders, reports Genetic Engineering and Biotechnology News ... approaches to preserve the ability of the BBB to ... and to permit the passage of effective medicines for ...
    ... plant pollen grains, sperm cells, which carry the genetic ... within larger "companion" cells that are called pollen vegetative ... nourishment, and push them towards their targets during fertilization. ... Spring Harbor Laboratory (CSHL) led by Professor Robert Martienssen, ...
    Cached Biology News:Federal scientists recognized for contributions to knowledge of bird ecology and habitat 2GEN reports on strategies to overcome blood-brain barrier 2CSHL scientists discover how 'companion' cells to sperm protect them from genetic damage 2CSHL scientists discover how 'companion' cells to sperm protect them from genetic damage 3
    ... The kit measures mitochondria intactness ... mitochondrial membrane potential. Features and Benefits: ... method for staining isolated mitochondria and ... Contains all the reagents required for ...
    ... dispensers save space and organize ... and other garb. They are ... for small parts used in ... acrylic. Many other sizes and ...
    ... These handy dispensers save space and ... and other garb. They are the ... parts used in labs, processing and ... charges and the particles they attract. ...
    ... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Mammals microRNA Microarray ...
    Biology Products: